Skip to Content
Merck
CN

162345

3-(3,4-Dimethoxyphenyl)propionic acid

99%

Synonym(s):

3,4-Dimethoxyhydrocinnamic acid

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
(CH3O)2C6H3CH2CH2CO2H
CAS Number:
Molecular Weight:
210.23
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
218-288-3
Beilstein/REAXYS Number:
2696272
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

3-(3,4-Dimethoxyphenyl)propionic acid, 99%

InChI key

LHHKQWQTBCTDQM-UHFFFAOYSA-N

InChI

1S/C11H14O4/c1-14-9-5-3-8(4-6-11(12)13)7-10(9)15-2/h3,5,7H,4,6H2,1-2H3,(H,12,13)

SMILES string

COc1ccc(CCC(O)=O)cc1OC

assay

99%

form

solid

mp

96-97 °C (lit.)

functional group

carboxylic acid

Looking for similar products? Visit Product Comparison Guide

Application

3-(3,4-Dimethoxyphenyl)propionic acid was used in screening of short-chain fatty acid derivatives for the ability to induce γ globin gene expression in reporter assays and erythropoiesis in vivo.

General description

3-(3,4-Dimethoxyphenyl)propionic acid (3,4-Dimethoxyhydrocinnamic acid) forms complex with copper (II).

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Metal-cinnamic acids interactions. Part IV. Synthesis, study and antimicrobial activity of copper (II) complexes of 3, 4-dimethoxyhydrocinnamic acid.
Zoroddu MA and Berardi E.
Transition Met. Chem. (London), 14(4), 269-272 (1989)
Betty S Pace et al.
Blood, 100(13), 4640-4648 (2002-10-24)
Orally bioactive compounds that induce gamma globin gene expression at tolerable doses are needed for optimal treatment of the beta-hemoglobinopathies. Short-chain fatty acids (SCFAs) of 2 to 6 carbons in length induce gamma globin expression in animal models, and butyrate

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service